The Travelers Companies, Inc. (TRV)

The Travelers Companies is trading near the top of its 52-week range, with the price at $399.46 against a 52-week high of $418.00. The stock has been firm over the past year, up 39.66%, and sits above its 50-day and 200-day moving averages ($379.64 and $334.83). The main debate is whether a valuation that screens far below sector peers can hold up against analysts who mostly stay on the sidelines and expect earnings to fall next year. CleaRank rates the stock Buy, scoring it 76 out of 100, while Wall Street's consensus is Hold.

The trend is the strongest part of the picture. The price is 5.22% above its 50-day average and 19.30% above its 200-day average, and the 50-day average itself sits 13.38% above the 200-day average. The 14-day RSI is 57.5, in the neutral zone, and the MACD line is positive. That combination suggests buyers have kept control over a long stretch, though the stock has softened over the past week, down 2.39%, and remains 4.44% below its 52-week high.

The stock looks cheap on the numbers CleaRank tracks. The trailing P/E of 10.54 is 36.1% below the sector median of 16.5, and the price-to-sales ratio of 1.68 is 55.8% below the sector median of 3.8. Reported earnings per share over the last 12 months were $38.03, and the return on equity of 27.50% is well above the sector median of 13.8%. Net margin of 16.9% and a debt-to-equity ratio of 0.34 support the view that the business is financially sturdy.

The October 16, 2026 report showed adjusted EPS of $9.18 against a $7.43 estimate, a beat of 23.55%, yet the stock fell 1.05% in the first session after the report. Across the last eight reports, EPS beat the estimate in every case and missed in none. The largest first-session move after an earlier report came after January 21, 2026, when the stock rose 2.14% after EPS came in 23.99% above the estimate.

Insiders sold $176.0M of stock over the last 18 months across 60 sales and made no open-market purchases. Those sales are often planned in advance or made to cover taxes on vesting shares, so they are a weaker signal than purchases would be.

The base case is that the stock keeps trending higher while the earnings base stays strong. The trailing P/E of 10.54 sits well below the sector median of 16.5, and the price already sits 5.3% above the analysts' median target of $379.50, so further gains would need the market to accept a higher multiple or steadier growth. Analysts expect EPS to grow 33.4% this fiscal year to $36.80 but to shrink 15.5% next year to $31.11, and revenue is expected to shrink 0.9% this year. Upside would come from another quarter of earnings beats and from revenue growth that picks up from the 0.31% achieved last quarter. The downside case is a pullback toward the 50-day average if estimates keep falling or the sector loses its appeal. The analysts' target range runs from $262.00 to $460.00, so the spread of views is wide.

Support sits first at the 20-day exponential moving average of $394.17, which the price is only just above and which a fall would meet first. Below that is the 50-day simple moving average at $379.64, followed by the 200-day simple moving average at $334.83. The 52-week low of $268.00 is the furthest support. Resistance is the 52-week high of $418.00, and a move through it would mark a new high for the stock.